Literature DB >> 30942940

The role of the T-N tract in advanced stage tongue cancer.

Marta Tagliabue1, Sara Gandini2, Fausto Maffini3, Valeria Navach1, Roberto Bruschini1, Gioacchino Giugliano1, Francesca Lombardi4, Susanna Chiocca2, Elisabetta Rebecchi5, Eleonora Sica6, Massimo Tommasino7, Luca Calabrese1, Mohssen Ansarin1.   

Abstract

BACKGROUND: We investigated the role of the soft tissue tract between the primary tumor and the neck lymph nodes, the "T-N tract," in patients with tongue squamous cell carcinoma at an advanced stage.
METHODS: We performed a compartmental tongue surgery in 233 patients. Cumulative incidence of relapses and overall survival curves were compared by T-N tract involvement. Multivariate Cox proportional hazards models were used to assess the independent role of T-N tract.
RESULTS: At 4 years of follow-up, patients with disease in the T-N tract experienced a significantly more distant recurrence (40%) than did patients without T-N tract involvement (22%; P = .02). Multivariate Cox models indicate a significant almost triple risk of distant metastases (hazard ratio [HR], 2.70; 95% CI, 1.01-7.19; P = .05) and double risk of death (HR, 2.09; 95%CI, 1.13-3.85; P = .02) in patients with "T-N tract involvement."
CONCLUSIONS: Our data show that the T-N tract plays an important role in prognosis and survival in patients with tongue cancer.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  compartmental tongue surgery; lingual lymph nodes; oral cancer; squamous cell carcinoma; tongue cancer

Year:  2019        PMID: 30942940     DOI: 10.1002/hed.25761

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.

Authors:  Marta Tagliabue; Rita De Berardinis; Pietro Belloni; Sara Gandini; Donatella Scaglione; Fausto Maffini; Rosolino Antonino Mirabella; Stefano Riccio; Giugliano Gioacchino; Roberto Bruschini; Francesco Chu; Mohssen Ansarin
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

2.  Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection.

Authors:  Alberto Grammatica; Cesare Piazza; Marco Ferrari; Vincenzo Verzeletti; Alberto Paderno; Davide Mattavelli; Alberto Schreiber; Davide Lombardi; Enrico Fazio; Luca Gazzini; Giovanni Giorgetti; Barbara Buffoli; Luigi Fabrizio Rodella; Piero Nicolai; Luca Calabrese
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

3.  Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age.

Authors:  Mohssen Ansarin; Rita De Berardinis; Federica Corso; Gioacchino Giugliano; Roberto Bruschini; Luigi De Benedetto; Stefano Zorzi; Fausto Maffini; Fabio Sovardi; Carolina Pigni; Donatella Scaglione; Daniela Alterio; Maria Cossu Rocca; Susanna Chiocca; Sara Gandini; Marta Tagliabue
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

Review 4.  From Bench to Bedside in Tongue Muscle Cancer Invasion and Back again: Gross Anatomy, Microanatomy, Surgical Treatments and Basic Research.

Authors:  Luca Calabrese; Maria Eleonora Bizzoca; Roberto Grigolato; Fausto Antonio Maffini; Marta Tagliabue; Rosa Negro; Stefania Leuci; Michele Davide Mignogna; Lorenzo Lo Muzio
Journal:  Life (Basel)       Date:  2020-09-12

5.  Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.

Authors:  Sho Kawaguchi; Kenta Kawahara; Yukio Fujiwara; Koji Ohnishi; Cheng Pan; Hiromu Yano; Akiyuki Hirosue; Masashi Nagata; Masatoshi Hirayama; Junki Sakata; Hikaru Nakashima; Hidetaka Arita; Keisuke Yamana; Shunsuke Gohara; Yuka Nagao; Manabu Maeshiro; Asuka Iwamoto; Mayumi Hirayama; Ryoji Yoshida; Yoshihiro Komohara; Hideki Nakayama
Journal:  Cancer Immunol Immunother       Date:  2022-01-19       Impact factor: 6.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.